Prelude Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,589
Closed -$242K 1369
2025
Q4
$242K Buy
+3,589
New +$241K 0.02% 917
2019
Q2
Sell
-708
Closed -$11K 1851
2019
Q1
$11K Hold
708
﹤0.01% 1421
2018
Q4
$10K Hold
708
﹤0.01% 1370
2018
Q3
$13K Sell
708
-2,144
-75% -$37.6K ﹤0.01% 1403
2018
Q2
$48K Sell
2,852
-26,630
-90% -$504K ﹤0.01% 1129
2018
Q1
$578K Buy
29,482
+27,682
+1,538% +$536K 0.04% 406
2017
Q4
$36K Buy
+1,800
New +$33.1K ﹤0.01% 1007
2016
Q4
Sell
-1,600
Closed -$19K 1646
2016
Q3
$19K Sell
1,600
-11,300
-88% -$115K ﹤0.01% 1347
2016
Q2
$111K Buy
12,900
+8,705
+208% +$85.9K 0.02% 714
2016
Q1
$40K Sell
4,195
-1,505
-26% -$14.2K 0.01% 1010
2015
Q4
$99K Sell
5,700
-900
-14% -$14.3K 0.02% 815
2015
Q3
$89K Buy
6,600
+3,000
+83% +$60.2K 0.01% 877
2015
Q2
$81K Sell
3,600
-3,400
-49% -$59.8K 0.01% 958
2015
Q1
$100K Buy
+7,000
New +$101K 0.01% 1002
2014
Q2
Sell
-3,400
Closed -$43K 2022
2014
Q1
$43K Sell
3,400
-15,422
-82% -$229K 0.01% 1354
2013
Q4
$282K Hold
18,822
0.05% 518
2013
Q3
$208K Sell
18,822
-28,419
-60% -$237K 0.03% 530
2013
Q2
$376K Buy
+47,241
New +$301K 0.08% 308

Other funds holding HALO

Prelude Capital Management's HALO Position: Q1 2026 in Review

Prelude Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,589 shares — an estimated $242K sold.

Prelude Capital Management first reported a position in HALO in Q2 2013 and held it in 18 quarters. The position peaked at $578K in Q1 2018. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Prelude Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 3,589 Halozyme shares in Q1 2026, an estimated $242K.
  • Prelude Capital Management first reported a position in Halozyme in Q2 2013 and held it in 18 quarters.
  • Prelude Capital Management's Halozyme position peaked at $578K in Q1 2018.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.